Edap TMS SA

EDAP TMS SA develops and commercializes minimally invasive medical systems, centered on its Focal One robotic high-intensity focused ultrasound (HIFU) platform for prostate care. The company also has legacy lithotripsy (ESWL) and medical device distribution activities, with operations and sales across the United States, Europe, and other international markets.

−30,2 %

42,5 %

−41,5 %

+10,0 %

1.54

1.19

— Edap TMS SA
%
HIFU systems and treatment revenue65% Robotic HIFU systems, disposables, RPP arrangements, leases, and related services.
HIFU maintenance and installed-base services7% Maintenance contracts and support services for installed Focal One systems.
ESWL products and services8% Legacy lithotripsy consumables, spare parts, repair services, and residual system activity.
Distribution services20% Third-party medical device distribution and related consumables, leasing, and services.

EDAP sells primarily to hospitals, urology centers, and other healthcare providers that treat prostate and stone...

  • Hospitals and academic medical centersprimary

    Buy Focal One systems and related services to add minimally invasive prostate treatment capability.

  • Urology clinics and treatment centersprimary

    Use RPP and lease arrangements to access HIFU technology with lower upfront capital needs.

  • Installed-base ESWL customerssecondary

    Purchase consumables, spare parts, and repairs for existing lithotripsy systems.

  • Medical device distribution customerssecondary

    Buy third-party devices and related consumables through the distribution channel.

EDAP has a multinational footprint, with meaningful activity in the United States and Europe and additional sales in...

  • •United States is a key market for Focal One system placements
  • •Europe uses an RPP model for HIFU revenue generation
  • •Other jurisdictions support additional system sales and services
  • •Installed-base geography drives recurring maintenance and consumables demand
  • •Regional commercial models affect revenue timing and predictability

EDAP’s strategy is centered on expanding its proprietary HIFU franchise and reducing reliance on legacy ESWL and...

01
Expand HIFU commercializationshort-term

HIFU is the core proprietary platform and the main driver of future growth.

02
Build recurring revenue streamsmedium-term

RPP, leases, disposables, and maintenance reduce dependence on one-time equipment sales.

03
Reduce reliance on legacy businessesmedium-term

ESWL and distribution are lower-priority activities and less central to the company’s platform strategy.

EDAP depends on adoption of a specialized medical technology, so demand can be affected by hospital capital budgets,...

high

Dependence on HIFU adoption

The growth strategy relies on hospitals and clinics adopting Focal One and treatment workflows.

Scope
U.S. and Europe commercialization
Materiality
high
high

Financing and dilution risk

Commercialization and R&D needs may require additional capital if operating cash generation is insufficient.

Scope
Corporate funding
Materiality
high
medium

Revenue timing from leases and RPP contracts

Operating leases and revenue-per-procedure models spread revenue over time and can create quarter-to-quarter volatility.

Scope
HIFU division
Materiality
high
medium

Legacy business decline

ESWL system sales have ended and distribution agreements have been terminated, reducing legacy revenue streams.

Scope
ESWL and Distribution divisions
Materiality
medium
medium

Foreign exchange and tariff exposure

The company operates internationally and has disclosed tariff impact and euro-dollar sensitivity.

Scope
Europe and cross-border supply chain
Materiality
medium
Revenue recognition by business model
Can shift revenue between quarters and change gross margin mix
Fair value of warrants and debt-related instruments
Can create volatility in non-operating income or expense
Foreign currency translation and transaction effects
Can materially affect reported earnings and cash balances
Lease accounting and installed-base arrangements
Influences balance sheet structure and recurring revenue profile

TELEPHONE & DATA SYSTEMS INC /DE/

TDS · Telephone Communications (No Radiotelephone)

Edesa Biotech, Inc.

EDSA · Pharmaceutical Preparations

Teads Holding Co.

TEAD · Services-Computer Programming, Data Processing, Etc.

ADAMAS TRUST, INC.

ADAM · Real Estate Investment Trusts

ADC Therapeutics SA

ADCT · Pharmaceutical Preparations

AUTOMATIC DATA PROCESSING INC

ADP · Services-Computer Processing & Data Preparation

: 16.6.2026